ABSTRACT

Fact Sheet for Healthcare Providers: Diazyme Laboratories, Inc. Diazyme DZ-Lite SARS-CoV-2 IgG CLIA Kit   [open pdf - 80KB]

From the Document: "This Fact Sheet informs you of the significant known and potential risks and benefits of the emergency use of Diazyme DZ-Lite SARS-CoV-2 [severe acute respiratory syndrome coronavirus 2] IgG [Immunoglobulin G] CLIA [Clinical Laboratory Improvement Amendments] Kit. The Diazyme DZ-Lite SARS-CoV-2 IgG CLIA Kit is authorized for the detection of IgG antibodies to SARS-CoV-2 in human serum or plasma (potassium EDTA [ethylenediaminetetraacetic acid], disodium EDTA and lithium heparin)."

Publisher:
Date:
2020-07-08
Series:
Copyright:
Public Domain
Retrieved From:
U.S. Food and Drug Administration: https://www.fda.gov/
Format:
pdf
Media Type:
application/pdf
URL:
Help with citations